Comparing “hybrid closed loop” artificial pancreas therapy to multi daily injection, insulin pump without CGM and insulin pump with CGM in partially open loop therapies for diabetes type-1 patients

Abstract

Background and Aims. This study will prove that diabetes T1 therapy by means of artificial pancreas consisting on insulin pump with CGM and hybrid close loop control algorithm trained with machine learning technology provides better glycemia control than multi daily injection, insulin pump without CGM and insulin pump with CGM in partially open loop therapies